# Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

> **NCT03251287** · PHASE1 · UNKNOWN · sponsor: **University of East Anglia** · enrollment: 18 (estimated)

## Conditions studied

- Cardiomyopathy, Hypertrophic

## Interventions

- **DRUG:** Sodium Nitrate
- **DRUG:** Placebo
- **DIAGNOSTIC_TEST:** Phosphorous Magnetic Resonance Spectroscopy
- **DIAGNOSTIC_TEST:** Exercise Stress Transthoracic Echocardiogram

## Key facts

- **NCT ID:** NCT03251287
- **Lead sponsor:** University of East Anglia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2017-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251287, "Nitrite in Hypertrophic Cardiomyopathy (HCM) Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03251287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*